TNSN04055A1 - Formes cristallines anhydres de gabapentine - Google Patents

Formes cristallines anhydres de gabapentine

Info

Publication number
TNSN04055A1
TNSN04055A1 TNP2004000055A TNSN04055A TNSN04055A1 TN SN04055 A1 TNSN04055 A1 TN SN04055A1 TN P2004000055 A TNP2004000055 A TN P2004000055A TN SN04055 A TNSN04055 A TN SN04055A TN SN04055 A1 TNSN04055 A1 TN SN04055A1
Authority
TN
Tunisia
Prior art keywords
gabapentine
crystalline forms
anhydrous crystalline
forms
new crystalline
Prior art date
Application number
TNP2004000055A
Other languages
English (en)
Inventor
Linna R Chen
Suresh R Babu
Claude Jeffrey Calvitt
Brian TOBIAS
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of TNSN04055A1 publication Critical patent/TNSN04055A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

IL EST DECRIT DES FORMES ANHYDRES CRISTALLINES NOUVELLES DE GABAPENTINE FORMEES A PARTIR DE MONOHYDRATE DE GABAPENTINE. LES FORMES CRISTALLINES NOUVELLES PRESENTENT DES AVANTAGES DANS LA PRODUCTION DE L'AGENT THERAPEUTIQUE.
TNP2004000055A 2001-10-09 2004-04-07 Formes cristallines anhydres de gabapentine TNSN04055A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32837501P 2001-10-09 2001-10-09
US10/256,155 US6800782B2 (en) 2001-10-09 2002-09-25 Anhydrous crystalline forms of gabapentin
PCT/US2002/031706 WO2003031391A1 (fr) 2001-10-09 2002-10-03 Nouvelles formes cristallines anhydres de gabapentine

Publications (1)

Publication Number Publication Date
TNSN04055A1 true TNSN04055A1 (fr) 2006-06-01

Family

ID=26945177

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2004000055A TNSN04055A1 (fr) 2001-10-09 2004-04-07 Formes cristallines anhydres de gabapentine

Country Status (27)

Country Link
US (1) US6800782B2 (fr)
EP (1) EP1463712A1 (fr)
JP (1) JP2005505594A (fr)
KR (1) KR20050033525A (fr)
CN (1) CN1568305A (fr)
AP (1) AP2004003025A0 (fr)
BG (1) BG108702A (fr)
BR (1) BR0213156A (fr)
CA (1) CA2462331A1 (fr)
CO (1) CO5570697A2 (fr)
CZ (1) CZ2004416A3 (fr)
EA (1) EA006557B1 (fr)
GE (1) GEP20063936B (fr)
HR (1) HRP20040408A2 (fr)
HU (1) HUP0401782A3 (fr)
IL (1) IL161099A0 (fr)
IS (1) IS7195A (fr)
MA (1) MA27072A1 (fr)
MX (1) MXPA04003301A (fr)
NO (1) NO20041370L (fr)
NZ (1) NZ531993A (fr)
OA (1) OA12665A (fr)
PL (1) PL368117A1 (fr)
RS (1) RS28204A (fr)
SK (1) SK1572004A3 (fr)
TN (1) TNSN04055A1 (fr)
WO (1) WO2003031391A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043236A1 (en) * 2003-05-19 2007-02-22 Chandiran Thakashina M Process for preparation of gabapentin
WO2004106281A1 (fr) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Gabapentine cristallin
WO2004110342A2 (fr) * 2003-06-12 2004-12-23 Matrix Laboratories Ltd Nouveau polymorphe de gabapentine et sa conversion en gabapentine de forme ii
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
ITMI20040579A1 (it) * 2004-03-25 2004-06-25 Zambon Spa Processo di preparazione di gabapentina
WO2010023694A2 (fr) * 2008-09-01 2010-03-04 Hikal Ltd Formes cristallines de la gabapentine et leur procédé
CN104649921B (zh) * 2015-01-14 2016-09-28 天津大学 一种加巴喷丁与己二酸共晶及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
JPS62247160A (ja) * 1986-03-31 1987-10-28 Aisin Seiki Co Ltd スタ−リングエンジンの始動装置
US4960931A (en) * 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US4894476A (en) * 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
DE3928184A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
IL119890A (en) 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii
ES2137137B1 (es) 1998-05-25 2000-08-16 Medichem Sa Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.

Also Published As

Publication number Publication date
US6800782B2 (en) 2004-10-05
MXPA04003301A (es) 2004-07-23
NO20041370L (no) 2004-04-01
US20030092933A1 (en) 2003-05-15
HUP0401782A2 (hu) 2005-10-28
IL161099A0 (en) 2004-08-31
BG108702A (en) 2005-05-31
HRP20040408A2 (en) 2004-10-31
PL368117A1 (en) 2005-03-21
OA12665A (en) 2006-06-19
EP1463712A1 (fr) 2004-10-06
JP2005505594A (ja) 2005-02-24
HUP0401782A3 (en) 2006-01-30
MA27072A1 (fr) 2004-12-20
RS28204A (en) 2006-12-15
GEP20063936B (en) 2006-10-10
CO5570697A2 (es) 2005-10-31
KR20050033525A (ko) 2005-04-12
WO2003031391A1 (fr) 2003-04-17
BR0213156A (pt) 2004-09-14
CN1568305A (zh) 2005-01-19
EA200400417A1 (ru) 2004-10-28
AP2004003025A0 (en) 2004-06-30
IS7195A (is) 2004-03-23
NZ531993A (en) 2006-09-29
CA2462331A1 (fr) 2003-04-17
CZ2004416A3 (cs) 2005-03-16
EA006557B1 (ru) 2006-02-24
SK1572004A3 (sk) 2005-03-04

Similar Documents

Publication Publication Date Title
EP2085391A3 (fr) Inhibiteurs de facteur XA et autres sérines protéases impliquées dans la cascade de coagulation
EP1769791A3 (fr) Strategies therapeutiques pour la prevention et le traitement de la maladie d'alzheimer
MA25654A1 (fr) Cristallisation selective du sel de sodium de l'acide 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonique, sous la forme hemipentahydrate au monohydrate.
EE200300001A (et) Perindopriili tert-butüülamiinsoola kristallilinealfa-vorm
EA200401114A3 (ru) Замещённые гидроксиэтиламины
FR2780403B3 (fr) Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
TNSN04055A1 (fr) Formes cristallines anhydres de gabapentine
ITMI20000837A0 (it) Processo per la sintesi di cefoperazone sodico ad elevata cristallimita'
EA200201234A1 (ru) Производные сульфонамида
ATE267600T1 (de) Mikroemulsionen zur transdermalen verabreichung von apomorphin für die behandlung von morbus parkinson
ITMI20010964A0 (it) Procedimento per l'ottenimento di composti utili per la produzione del cefotetan e nuovi composti cosi' ottenuti
RU99102949A (ru) Препарат "антигриппин"
HUP0100887A2 (hu) Bibapcitid-bázisú gyógyszerkészítmények trombusok leképezésére és kezelésére
RU2003117877A (ru) Фармацевтическая композиция для лечения воспалительных процессов вирусной этиологии в глазном яблоке
TH56658EX (th) ที่ยึดไหมขัดฟัน
DE60128077D1 (de) Verbindung für die Behandlung von atherosclerotischen und thrombotischen Erkrankungen
TH58940EX (th) แปรงสีฟัน
TH58941EX (th) แปรงสีฟัน
TH55735EX (th) ส่วนปลายของแปรงสีฟัน
HUP0203476A2 (en) Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate, use thereof and pharmaceutical composition containing the same
TH44240EX (th) รถเข็นนั่งสำหรับผู้ป่วย
TH56543EX (th) ที่ยึดไหมขัดฟัน
ITMI20030845A1 (it) Procedimento ed impianto per la produzione di lastre alveolari di policarbonato e lastre alveolari cosi' ottenute
RU2000106783A (ru) Препарат для лечения пародонтоза